Premium
Experience With NovoPen®, an Injection Device using Cartridged Insulin, for Diabetic Patients
Author(s) -
Walters D. P.,
Smith P. A.,
Marteau T. M.,
Brimble A.,
Borthwick L. J.
Publication year - 1985
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/j.1464-5491.1985.tb00691.x
Subject(s) - medicine , syringe , evening , regimen , insulin , diabetes mellitus , human insulin , surgery , endocrinology , physics , astronomy , psychiatry
An insulin injection device, NovoPen®, incorporating cartridged U100 Human Actrapid insulin was used in a group of 31 insulin‐dependent diabetic patients aged 31.4±11.2 years (mean±S.D.; range 16.5–57.0) to assess its acceptance and suitability in a regimen involving an injection before each of their three main meals plus an evening injection of Human Monotard® insulin from a conventional syringe. Twenty‐seven patients completed 48 weeks of NovoPen® therapy and preferred to continue with the multiple injection regimen in the long term. The device was well accepted and may make multiple injection regimens more feasible.